Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $87 | $4,424 | $6,882 | $7,211 |
| - Cash | $3,623 | $2,401 | $2,861 | $7,483 |
| + Debt | $2,924 | $3,524 | $4,124 | $743,840 |
| Enterprise Value | -$612 | $5,546 | $8,145 | $743,569 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9,428 | -$9,275 | -$8,563 | -$20,268 |
| % Margin | – | – | – | – |
| Net Income | -$8,962 | -$8,687 | -$9,381 | -$21,463 |
| % Margin | – | – | – | – |
| EPS Diluted | -66.85 | -337.47 | -22.97 | -28,543.2 |
| % Growth | 80.2% | -1,369.2% | 99.9% | – |
| Operating Cash Flow | -$7,857 | -$7,864 | -$8,481 | -$5,720 |
| Capital Expenditures | $0 | $0 | -$250 | -$625 |
| Free Cash Flow | -$7,857 | -$7,864 | -$8,731 | -$6,345 |